CYP-17 inhibitor therapy

CYP17 inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CYP-17 inhibitor therapy, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy